| Reference |
|---|
Schank M, Zhao J, Wang L, Nguyen L, Zhang Y, Wu X, et al. ROS-Induced Mitochondrial Dysfunction in CD4 T Cells from ART-Controlled People Living with HIV. Viruses. 2023;15: pubmed publisher |
Wongchang T, Pluangnooch P, Hongeng S, Wongkajornsilp A, Thumkeo D, Soontrapa K. Inhibition of DYRK1B suppresses inflammation in allergic contact dermatitis model and Th1/Th17 immune response. Sci Rep. 2023;13:7058 pubmed publisher |
Islam M, Sevak J, Sharma M, Jindal A, Vyas A, Bajpai M, et al. Immune predictors of hepatitis B surface antigen seroconversion in patients with hepatitis B reactivation. Aliment Pharmacol Ther. 2023;57:689-708 pubmed publisher |
Rivera Cruz C, Figueiredo M. Evaluation of human adipose-derived mesenchymal stromal cell Toll-like receptor priming and effects on interaction with prostate cancer cells. Cytotherapy. 2023;25:33-45 pubmed publisher |
Kim H, Ho T, Willner M, Becker M, Kim H, Leong K. Dendritic cell-mimicking scaffolds for ex vivo T cell expansion. Bioact Mater. 2023;21:241-252 pubmed publisher |
Ogura H, Gohda J, Lu X, Yamamoto M, Takesue Y, Son A, et al. Dysfunctional Sars-CoV-2-M protein-specific cytotoxic T lymphocytes in patients recovering from severe COVID-19. Nat Commun. 2022;13:7063 pubmed publisher |
Ren X, Corrigan D, Zang X. Protocol for evaluating antitumor activity of KIR3DL3 blockade in an NK cell-based xenogeneic lung tumor model. STAR Protoc. 2022;3:101818 pubmed publisher |
Yoon H, Kim G, Oh S, Kim H, Kim Y, Lee Y, et al. WNK3 inhibition elicits antitumor immunity by suppressing PD-L1 expression on tumor cells and activating T-cell function. Exp Mol Med. 2022;54:1913-1926 pubmed publisher |
Sungur C, Wang Q, Ozant xfc rk A, Gao H, Schmitz A, Cella M, et al. Human NK cells confer protection against HIV-1 infection in humanized mice. J Clin Invest. 2022;132: pubmed publisher |
Senger K, Akhmetzyanova I, Haley B, Rutz S, Oh S. Plasmid-Based Donor Templates for Nonviral CRISPR/Cas9-Mediated Gene Knock-In in Human T Cells. Curr Protoc. 2022;2:e538 pubmed publisher |
Jowett G, Read E, Roberts L, Coman D, Vil xe0 Gonz xe1 lez M, Zabinski T, et al. Organoids capture tissue-specific innate lymphoid cell development in mice and humans. Cell Rep. 2022;40:111281 pubmed publisher |
Muik A, Adams 3rd H, Gieseke F, Altintas I, Schoedel K, Blum J, et al. DuoBody-CD40x4-1BB induces dendritic-cell maturation and enhances T-cell activation through conditional CD40 and 4-1BB agonist activity. J Immunother Cancer. 2022;10: pubmed publisher |
Baleeiro R, Bouwens C, Liu P, DI Gioia C, Dunmall L, Nagano A, et al. MHC class II molecules on pancreatic cancer cells indicate a potential for neo-antigen-based immunotherapy. Oncoimmunology. 2022;11:2080329 pubmed publisher |
Law A, Chen J, Colino Sanguino Y, Fuente L, Fang G, Grimes S, et al. ALTEN: A High-Fidelity Primary Tissue-Engineering Platform to Assess Cellular Responses Ex Vivo. Adv Sci (Weinh). 2022;9:e2103332 pubmed publisher |
Zhang Y, Trang V, Palmer D, Kishton R, Gong L, Huang J, et al. A T cell resilience model associated with response to immunotherapy in multiple tumor types. Nat Med. 2022;: pubmed publisher |
Bunting M, Vyas M, Requesens M, Langenbucher A, Schiferle E, Manguso R, et al. Extracellular matrix proteins regulate NK cell function in peripheral tissues. Sci Adv. 2022;8:eabk3327 pubmed publisher |
Ye L, Park J, Peng L, Yang Q, Chow R, Lam S, et al. A genome-scale gain-of-function CRISPR screen in CD8 T cells identifies proline metabolism as a means to enhance CAR-T therapy. Cell Metab. 2022;34:595-614.e14 pubmed publisher |
Su Y, Yuan D, Chen D, Ng R, Wang K, Choi J, et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185:881-895.e20 pubmed publisher |
Lin Y, Liu S, Wu W, Shen Y, Wang Y, Liao C, et al. miR-4759 suppresses breast cancer through immune checkpoint blockade. Comput Struct Biotechnol J. 2022;20:241-251 pubmed publisher |
Zhang Z, Yang A, Chaurasiya S, Park A, Lu J, Kim S, et al. CF33-hNIS-antiPDL1 virus primes pancreatic ductal adenocarcinoma for enhanced anti-PD-L1 therapy. Cancer Gene Ther. 2022;29:722-733 pubmed publisher |
Rafieerad A, Yan W, Alagarsamy K, Srivastava A, Sareen N, Arora R, et al. Fabrication of Smart Tantalum Carbide MXene Quantum Dots with Intrinsic Immunomodulatory Properties for Treatment of Allograft Vasculopathy. Adv Funct Mater. 2021;31:2106786 pubmed publisher |
Yi K, Cui X, Liu X, Wang Y, Zhao J, Yang S, et al. PTRF/Cavin-1 as a Novel RNA-Binding Protein Expedites the NF-κB/PD-L1 Axis by Stabilizing lncRNA NEAT1, Contributing to Tumorigenesis and Immune Evasion in Glioblastoma. Front Immunol. 2021;12:802795 pubmed publisher |
Wang Y, Zheng K, Xiong H, Huang Y, Chen X, Zhou Y, et al. PARP Inhibitor Upregulates PD-L1 Expression and Provides a New Combination Therapy in Pancreatic Cancer. Front Immunol. 2021;12:762989 pubmed publisher |
Zhou Z, Van der Jeught K, Fang Y, Yu T, Li Y, Ao Z, et al. An organoid-based screen for epigenetic inhibitors that stimulate antigen presentation and potentiate T-cell-mediated cytotoxicity. Nat Biomed Eng. 2021;5:1320-1335 pubmed publisher |
Boothby I, Kinet M, Boda D, Kwan E, Clancy S, Cohen J, et al. Early-life inflammation primes a T helper 2 cell-fibroblast niche in skin. Nature. 2021;599:667-672 pubmed publisher |
Arora S, Thompson P, Wang Y, Bhattacharyya A, Apostolopoulou H, Hatano R, et al. Invariant Natural Killer T cells coordinate removal of senescent cells. Med. 2021;2:938-950 pubmed publisher |
Hutcherson S, Bedsaul J, Pomerantz J. Pathway-Specific Defects in T, B, and NK Cells and Age-Dependent Development of High IgE in Mice Heterozygous for a CADINS-Associated Dominant Negative CARD11 Allele. J Immunol. 2021;207:1150-1164 pubmed publisher |
Li C, Chi H, Deng S, Wang H, Yao H, Wang Y, et al. THADA drives Golgi residency and upregulation of PD-L1 in cancer cells and provides promising target for immunotherapy. J Immunother Cancer. 2021;9: pubmed publisher |
Wu S, Xiao Y, Wei J, Xu X, Jin X, Hu X, et al. MYC suppresses STING-dependent innate immunity by transcriptionally upregulating DNMT1 in triple-negative breast cancer. J Immunother Cancer. 2021;9: pubmed publisher |
Wei J, Wu S, Yang Y, Xiao Y, Jin X, Xu X, et al. GCH1 induces immunosuppression through metabolic reprogramming and IDO1 upregulation in triple-negative breast cancer. J Immunother Cancer. 2021;9: pubmed publisher |
Aguilar Díaz De León J, Glenn H, Knappenberger M, Borges C. Oxidized-Desialylated Low-Density Lipoprotein Inhibits the Antitumor Functions of Lymphokine Activated Killer Cells. J Cancer. 2021;12:4993-5004 pubmed publisher |
Schiferle E, Cheon S, Ham S, Son H, Messerschmidt J, Lawrence D, et al. Rejection of benign melanocytic nevi by nevus-resident CD4+ T cells. Sci Adv. 2021;7: pubmed publisher |
Virtakoivu R, Rannikko J, Viitala M, Vaura F, Takeda A, L xf6 nnberg T, et al. Systemic Blockade of Clever-1 Elicits Lymphocyte Activation Alongside Checkpoint Molecule Downregulation in Patients with Solid Tumors: Results from a Phase I/II Clinical Trial. Clin Cancer Res. 2021;27:4205-4220 pubmed publisher |
Zhao J, Schank M, Wang L, Li Z, Nguyen L, Dang X, et al. Mitochondrial Functions Are Compromised in CD4 T Cells From ART-Controlled PLHIV. Front Immunol. 2021;12:658420 pubmed publisher |
Xu H, Van der Jeught K, Zhou Z, Zhang L, Yu T, Sun Y, et al. Atractylenolide I enhances responsiveness to immune checkpoint blockade therapy by activating tumor antigen presentation. J Clin Invest. 2021;131: pubmed publisher |
Shang M, Yang H, Yang R, Chen T, Fu Y, Li Y, et al. The folate cycle enzyme MTHFD2 induces cancer immune evasion through PD-L1 up-regulation. Nat Commun. 2021;12:1940 pubmed publisher |
Khanam A, Ayithan N, Tang L, Poonia B, Kottilil S. IL-21-Deficient T Follicular Helper Cells Support B Cell Responses Through IL-27 in Patients With Chronic Hepatitis B. Front Immunol. 2020;11:599648 pubmed publisher |
Henrich I, Jain K, Young R, Quick L, Lindsay J, Park D, et al. Ubiquitin-specific protease 6 functions as a tumor suppressor in Ewing Sarcoma through immune activation. Cancer Res. 2021;: pubmed publisher |
Rodda L, Netland J, Shehata L, Pruner K, Morawski P, Thouvenel C, et al. Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19. Cell. 2021;184:169-183.e17 pubmed publisher |
Yang J, Zhang J, Lu R, Tan Y, Du G, Zhou G. T cell-derived exosomes induced macrophage inflammatory protein-1α/β drive the trafficking of CD8+ T cells in oral lichen planus. J Cell Mol Med. 2020;24:14086-14098 pubmed publisher |
Mehta N, Maddineni S, Kelly R, Lee R, Hunter S, Silberstein J, et al. An engineered antibody binds a distinct epitope and is a potent inhibitor of murine and human VISTA. Sci Rep. 2020;10:15171 pubmed publisher |
Rodda L, Netland J, Shehata L, Pruner K, Morawski P, Thouvenel C, et al. Functional SARS-CoV-2-specific immune memory persists after mild COVID-19. Res Sq. 2020;: pubmed publisher |
Rodda L, Netland J, Shehata L, Pruner K, Morawski P, Thouvenel C, et al. Functional SARS-CoV-2-specific immune memory persists after mild COVID-19. medRxiv. 2020;: pubmed publisher |
Hurrell B, Galle Treger L, Jahani P, Howard E, Helou D, Banie H, et al. TNFR2 Signaling Enhances ILC2 Survival, Function, and Induction of Airway Hyperreactivity. Cell Rep. 2019;29:4509-4524.e5 pubmed publisher |
Tang M, Cheng L, Li F, Wu B, Chen P, Zhan Y, et al. Transcription Factor IRF4 Dysfunction Affects the Immunosuppressive Function of Treg Cells in Patients with Primary Immune Thrombocytopenia. Biomed Res Int. 2019;2019:1050285 pubmed publisher |
Cho A, Caldara A, Ran N, Menne Z, Kauffman R, Affer M, et al. Single-Cell Analysis Suggests that Ongoing Affinity Maturation Drives the Emergence of Pemphigus Vulgaris Autoimmune Disease. Cell Rep. 2019;28:909-922.e6 pubmed publisher |
Guo J, Muse E, Christians A, Swanson S, Davila E. An Anticancer Drug Cocktail of Three Kinase Inhibitors Improved Response to a Dendritic Cell-Based Cancer Vaccine. Cancer Immunol Res. 2019;7:1523-1534 pubmed publisher |
Xhangolli I, Dura B, Lee G, Kim D, Xiao Y, Fan R. Single-cell Analysis of CAR-T Cell Activation Reveals A Mixed TH1/TH2 Response Independent of Differentiation. Genomics Proteomics Bioinformatics. 2019;: pubmed publisher |
Vidard L, Dureuil C, Baudhuin J, Vescovi L, Durand L, Sierra V, et al. CD137 (4-1BB) Engagement Fine-Tunes Synergistic IL-15- and IL-21-Driven NK Cell Proliferation. J Immunol. 2019;: pubmed publisher |
Malaker S, Pedram K, Ferracane M, Bensing B, Krishnan V, Pett C, et al. The mucin-selective protease StcE enables molecular and functional analysis of human cancer-associated mucins. Proc Natl Acad Sci U S A. 2019;116:7278-7287 pubmed publisher |
Liu Y, Lightfoot Y, Seto N, Carmona Rivera C, Moore E, Goel R, et al. Peptidylarginine deiminases 2 and 4 modulate innate and adaptive immune responses in TLR-7-dependent lupus. JCI Insight. 2018;3: pubmed publisher |
Jenks S, Cashman K, Zumaquero E, Marigorta U, Patel A, Wang X, et al. Distinct Effector B Cells Induced by Unregulated Toll-like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus Erythematosus. Immunity. 2018;49:725-739.e6 pubmed publisher |
Jiao S, Xia W, Yamaguchi H, Wei Y, Chen M, Hsu J, et al. PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression. Clin Cancer Res. 2017;23:3711-3720 pubmed publisher |
Malu D, Bélanger B, Desautels F, Kelendji K, Dalko E, Sanchez Dardon J, et al. Macrophage migration inhibitory factor: a downregulator of early T cell-dependent IFN-gamma responses in Plasmodium chabaudi adami (556 KA)-infected mice. J Immunol. 2011;186:6271-9 pubmed publisher |
